New Results

Codon arrangement modulates MHC-I peptides presentation: implications for a SARS-CoV-2 peptide-based vaccine

Tariq Daouda, Maude Dumont-Lagacé, Albert Feghaly, Alexandra-Chloé Villani
doi: https://doi.org/10.1101/2021.02.04.429819

Article Information

doi 
https://doi.org/10.1101/2021.02.04.429819
History 
  • February 4, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Tariq Daouda1,2,3,4,*,#,
  2. Maude Dumont-Lagacé5,*,
  3. Albert Feghaly5 and
  4. Alexandra-Chloé Villani1,2,3,4
  1. 1Broad Institute of MIT and Harvard, Cambridge, United States
  2. 2Center for Cancer Research, Massachusetts General Hospital, Charlestown, United States
  3. 3Department of Medicine, Harvard Medical School, Boston, United States
  4. 4Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Charlestown, United States
  5. 5Institute for Research in Immunology and Cancer; Université de Montréal; Montréal, Québec H3C 3J7, Canada
  1. ↵# Corresponding author; email: tariq.daouda{at}gmail.com

  1. ↵* These authors contributed equally.

Back to top
Posted February 04, 2021.
Download PDF

Supplementary Material

Email
Codon arrangement modulates MHC-I peptides presentation: implications for a SARS-CoV-2 peptide-based vaccine
Tariq Daouda, Maude Dumont-Lagacé, Albert Feghaly, Alexandra-Chloé Villani
bioRxiv 2021.02.04.429819; doi: https://doi.org/10.1101/2021.02.04.429819
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area